XML 17 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2016
REVENUES      
Product sales - net $ 602,541 $ 1,572,148 $ 1,276,882
Service and repair fees - net 9,124,728 9,537,040 9,396,736
Service and repair fees - related parties - net 110,000 110,000 110,000
Patient fee revenue, net of contractual allowances and discounts 39,165,413 36,400,600 32,985,809
Provision for bad debts for patient fee (17,896,528) (16,171,434) (14,539,786)
Management and other fees - net 41,422,958 38,361,514 36,633,230
Management and other fees - related party medical practices - net 8,986,882 8,226,718 7,505,339
Total Revenues - Net 81,515,994 78,036,586 73,368,210
COSTS AND EXPENSES      
Costs related to product sales 751,221 931,501 1,254,328
Costs related to service and repair fees 3,212,527 2,996,736 2,148,143
Costs related to service and repair fees -related parties 38,728 34,564 25,147
Costs related to patient fee revenue 10,256,951 8,987,673 9,418,935
Costs related to management and other fees 22,778,202 20,828,581 21,949,583
Costs related to management and other fees - related medical practices 4,913,141 4,273,370 4,074,762
Research and development 1,755,747 1,480,670 1,631,846
Selling, general and administrative, inclusive of compensatory element of stock issuances of $0, $2,397,276 and $2,006 for the years ended June 30, 2018, 2017 and 2016, respectively 18,125,266 19,407,411 18,509,850
Total Costs and Expenses 61,831,783 58,940,506 59,012,594
INCOME      
Income from Operations 19,684,211 19,096,080 14,355,616
Other Income and (Expenses):      
Interest expense (160,074) 28,299 (262,193)
Investment income 262,569 193,141 224,263
Other (expense) income - net (4,271) (1,156) 190,560
Income before benefit for income taxes and noncontrolling interests 19,782,435 19,316,364 14,508,246
Benefit for Income Taxes (5,669,750) (4,362,434) (4,287,271)
Net Income 25,452,185 23,678,798 18,795,517
Net Income - Noncontrolling Interests (4,221,383) (4,058,177) (3,070,892)
Net Income - Attributable to FONAR 21,230,802 19,620,621 15,724,625
Common Shares      
Other Income and (Expenses):      
Net Income - Attributable to FONAR $ 19,899,823 $ 18,390,586 $ 14,702,834
Basic Net Income Per Common Share $ 3.16 $ 2.98 $ 2.43
Diluted Net Income Per Common Share $ 3.1 $ 2.92 $ 2.38
Weighted Average Basic Shares Outstanding - Common Stockholders 6,287,510 6,161,599 6,050,893
Weighted Average Diluted Shares Outstanding - Common Stockholders 6,415,014 6,289,103 6,178,397
Class A Non Voting Preferred Stock      
Other Income and (Expenses):      
Net Income - Attributable to FONAR $ 992,005 $ 916,769 $ 761,561
Class C Common Stock      
Other Income and (Expenses):      
Net Income - Attributable to FONAR $ 338,974 $ 313,266 $ 260,230
Basic Net Income Per Common Share $ 0.89 $ 0.82 $ 0.68
Diluted Net Income Per Common Share $ 0.89 $ 0.82 $ 0.68
Weighted Average Basic Shares Outstanding - Common Stockholders 382,513 382,513 382,513
Weighted Average Diluted Shares Outstanding - Common Stockholders 382,513 382,513 382,513